Exosomal WIF‑1 from transient senescent adipose progenitors tunes Wnt signaling to balance repair and fibrosis

Michael Larsen· Mar 25, 2026

Mechanism: Chronic senescent adipose progenitors release WIF-1 via exosomes, suppressing Wnt signaling and driving fibrosis, while a youthful environment or anti-WIF-1 intervention reduces exosomal WIF-1, reactivating Wnt. Readout: Readout: Wnt activity (Axin2/TOPFlash) is restored, PPARγ expression increases, adipose fibrosis is reduced, and glucose tolerance improves.

Hypothesis

Transient senescent PDGFRα+ adipose progenitors release exosomes enriched in Wnt inhibitory factor‑1 (WIF‑1) that briefly dampen canonical Wnt/β‑catenin signaling in neighboring adipocyte progenitors, pausing differentiation to allow extracellular matrix remodeling and immune clearance. When senescence becomes chronic, sustained exosomal WIF‑1 drives prolonged Wnt suppression, shifting the tissue toward fibroblast activation, fibrosis and impaired adipogenesis. The reversible nature of the senescent phenotype observed in young systemic environments reflects a reduction in exosomal WIF‑1 output, restoring Wnt signaling and renegotiating the tissue’s repair contract.

Mechanistic Rationale

Recent work shows that acute senescent mesenchymal cells coordinate adaptive ECM synthesis, phagocyte recruitment and stem cell activation [1] and possess enhanced intercellular communication capacity [2]. In adipose tissue, chronic senescence secretes activin A, IL‑6, TNFα and IFN‑γ that block progenitor lipid accumulation and drive fibrotic encapsulation [3]. Exposure to a youthful circulation lowers p16/p21 and inflammatory SASP markers in old adipose cells [4], indicating the senescent state is plastic. We propose that, besides the canonical SASP, senescent adipose progenitors load exosomes with WIF‑1, a secreted antagonist that binds Wnt ligands and prevents Frizzled‑Lrp5/6 engagement. Transient WIF‑1 delivery creates a short‑lived Wnt‑low niche that halts adipogenic commitment, giving fibroblasts time to deposit provisional matrix and macrophages to clear debris. Persistent exosomal WIF‑1 maintains Wnt low, fostering a fibroblast‑myofibroblast switch, excess collagen deposition and hypoxia‑driven insulin resistance. The reversibility seen with young serum likely stems from decreased exosome biogenesis or altered cargo sorting, lowering WIF‑1 transfer and permitting Wnt re‑activation, which re‑engages adipogenic programs and loosens the fibrotic cage.

Testable Predictions

Exosomes isolated from senescent PDGFRα+ adipose progenitors (day 3 post‑injury) will contain higher WIF‑1 protein and mRNA than exosomes from non‑senescent progenitors; Western blot and qPCR of exosomal lysates will show this enrichment.
Adding senescent‑derived exosomes to primary adipocyte progenitors will reduce TOPFlash luciferase activity and decrease PPARγ expression, effects rescued by neutralizing WIF‑1 with antibodies or by GW4869‑mediated exosome release inhibition.
In vivo, obese mice treated with GW4869 or anti‑WIF‑1 antibodies will exhibit reduced adipose fibrosis and improved glucose tolerance despite unchanged p16^Ink4a^‑positive cell numbers, whereas senolytic clearance will produce similar metabolic benefits but also a transient spike in Wnt activity measurable by increased Axin2 expression.
Parabiosis of old obese mice with young partners will lower exosomal WIF‑1 levels in adipose tissue, correlating with decreased p16/p21 and restored Wnt reporter activity, linking systemic youth to exosome cargo remodeling.

Falsification: If senescent adipose exosomes do not enrich WIF‑1, or if exosomal WIF‑1 neutralization fails to modify Wnt signaling or fibrosis in the models above, the hypothesis is refuted.

Hypothesis

Mechanistic Rationale

Testable Predictions

Exosomes isolated from senescent PDGFRα+ adipose progenitors (day 3 post‑injury) will contain higher WIF‑1 protein and mRNA than exosomes from non‑senescent progenitors; Western blot and qPCR of exosomal lysates will show this enrichment.

Adding senescent‑derived exosomes to primary adipocyte progenitors will reduce TOPFlash luciferase activity and decrease PPARγ expression, effects rescued by neutralizing WIF‑1 with antibodies or by GW4869‑mediated exosome release inhibition.

In vivo, obese mice treated with GW4869 or anti‑WIF‑1 antibodies will exhibit reduced adipose fibrosis and improved glucose tolerance despite unchanged p16^Ink4a^‑positive cell numbers, whereas senolytic clearance will produce similar metabolic benefits but also a transient spike in Wnt activity measurable by increased Axin2 expression.

Parabiosis of old obese mice with young partners will lower exosomal WIF‑1 levels in adipose tissue, correlating with decreased p16/p21 and restored Wnt reporter activity, linking systemic youth to exosome cargo remodeling.

Falsification: If senescent adipose exosomes do not enrich WIF‑1, or if exosomal WIF‑1 neutralization fails to modify Wnt signaling or fibrosis in the models above, the hypothesis is refuted.